Endovascular Therapeutics India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.60 M
- Company Age 24 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Satisfied Charges ₹ 2.50 Cr
About Endovascular Therapeutics India
Endovascular Therapeutics India Private Limited (ETIPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2000 and has a history of 24 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Real Estate Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.60 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sam Mathew, Bina Mathew, and Mathew Kalarickal serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U33112MH2000PTC126063
- Company No.
126063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2000
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Endovascular Therapeutics India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sam Mathew  | Director | 26-Aug-2014 | Current |
| Bina Mathew | Director | 27-Aug-2008 | Current |
| Mathew Kalarickal | Director | 27-Aug-2008 | Current |
Financial Performance of Endovascular Therapeutics India.
Endovascular Therapeutics India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Endovascular Therapeutics India?
In 2017, Endovascular Therapeutics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
South Indian Green Cardamom Company LimitedSam Mathew and Bina Mathew are mutual person
_PRIVATE_LIMITED.webp)
Emergent Medi-Tech (India) Private LimitedSam Mathew is a mutual person
South Indian Cardamom Online Auction Private LimitedSam Mathew and Mathew Kalarickal are mutual person
- Golden-Nest Builders Private Limited
Sam Mathew, Bina Mathew and 1 more are mutual person
- Bengaluru Biomedicals Private Limited
Sam Mathew is a mutual person
- Medical Support Systems (India) Pvt Ltd
Sam Mathew is a mutual person
Charges (Loans)
₹5.00 M
₹25.00 M
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jan 2003 | Union Bank Of India | ₹5.00 M | Open |
| 21 Nov 2002 | Union Bank Of India | ₹2.50 Cr | Satisfied |
How Many Employees Work at Endovascular Therapeutics India?
Unlock and access historical data on people associated with Endovascular Therapeutics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Endovascular Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Endovascular Therapeutics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
